Homepage

Sensus Healthcare, Inc.

SRTS NASDAQ Categories PDF
Healthcare · Medical - Devices · United States · Updated May 10, 8:16pm
$3.08
Price
$50.7M
Market Cap
54
Employees
1.19
Beta
Joseph C. Sardano
CEO
Business Description

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Business History
Price Overview
Last updated: May 11, 2026 1:56pm (just now)
$3.40
+0.32 (+10.41%)
Day Range
$3.32 – $3.52
52-Week Range
$2.82 – $5.92
50-Day MA
$4.12
200-Day MA
$3.99
Volume
124,730.00
Analyst Price Targets
Low $6.00
Consensus $6.25
High $6.50
(4 analysts)
Share Structure
Outstanding 16,462,100.00
Float 13,548,933.00
Free Float 82.3%
High free float — 82.3% of shares trade freely, ~17.7% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-6.55
Stock Price: $3.08
EPS (Diluted): -0.47
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
1.35
Stock Price: $3.08
Total Equity: $48.10M
Shares: 16,326,937
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-4.44
Market Cap: $50.70M
Total Debt: $471,000
Cash: $22.08M
EBITDA: -$9.92M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$43.6M
Market Cap: $50.70M
Total Debt: $471,000
Cash: $22.08M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
43.2%
Gross Profit: $11.87M
Revenue: $27.48M
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-37.5%
Operating Income: -$10.31M
Revenue: $27.48M
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-28.1%
Net Income: -$7.72M
Revenue: $27.48M
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-15.8%
Net Income: -$7.72M
Total Equity: $48.10M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-17.8%
Operating Income: -$10.31M
Tax Rate: 19.8%
Equity: $48.10M
Total Debt: $471,000
Cash: $22.08M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
9.72
Current Assets: $45.89M
Current Liabilities: $4.72M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.01
Short-Term Debt: $262,000
Long-Term Debt: $209,000
Total Debt: $471,000
Total Equity: $48.10M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$1.68
Revenue: $27.48M
Shares: 16,326,937
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$2.95
Total Equity: $48.10M
Shares: 16,326,937
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$0.02
Operating CF: $528,000
CapEx: -$196,000
Shares: 16,326,937
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $3.08
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$7.72M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares SRTS against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $27.0M $44.5M $24.4M $41.8M $27.5M
Cost of Revenue $10.1M $14.9M $10.3M $17.4M $15.6M
Gross Profit $17.0M $29.6M $14.1M $24.4M $11.9M
Operating Expenses $12.9M $14.8M $14.4M $16.3M $22.2M
Operating Income $4.1M $14.8M $-382,000 $8.1M -$10.3M
Net Income $4.1M $24.2M $485,000 $6.6M -$7.7M
EBITDA $4.7M $15.3M $79,000 $8.5M -$9.9M
EPS $0.25 $1.47 $0.03 $0.41 $-0.47
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $14.5M $25.5M $23.1M $22.1M $22.1M
Total Current Assets $31.2M $53.2M $49.5M $56.7M $45.9M
Total Assets $32.2M $56.7M $53.7M $62.2M $53.0M
Current Liabilities $6.0M $7.7M $4.2M $5.9M $4.7M
Long-Term Debt $0 $0 $0 $0 $209,000
Total Liabilities $6.2M $8.7M $4.9M $6.3M $4.9M
Total Equity $26.0M $48.1M $48.8M $55.8M $48.1M
Retained Earnings -$17.9M $6.3M $6.8M $13.4M $5.7M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-286,000 -$1.4M -$2.1M $-831,000 $528,000
Capital Expenditure $-128,000 $-159,000 $-229,000 $-276,000 $-196,000
Free Cash Flow $-414,000 -$1.6M -$2.4M -$1.1M $332,000
Acquisitions (net) $257,000 $15.0M $0 $0 $0
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $-15,000 -$3.0M $-27,000 $0 $-300,000
Net Change in Cash $-388,000 $11.0M -$2.4M -$1.1M $27,000
Analyst Estimates (Annual)
Metric 2026 2027 2028 2029
Revenue $26.0M
$24.0M – $28.4M
 $36.2M
$28.9M – $45.6M
 $42.6M
$42.1M – $43.1M
 $78.5M
$72.6M – $86.0M
EBITDA $1.9M
$1.8M – $2.1M
 $2.6M
$2.1M – $3.3M
 $3.1M
$3.1M – $3.2M
 $5.7M
$5.3M – $6.3M
Net Income -$5.5M
-$6.1M – -$4.9M
 $204,087
$-279,276 – $687,449
 $1.5M
$353,750 – $1.8M
 $11.1M
$10.0M – $12.5M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth +64.7% -45.2% +71.3% -34.3%
Gross Profit Growth +74.4% -52.5% +73.8% -51.4%
Operating Income Growth +260.0% -102.6% +2,217.8% -227.4%
Net Income Growth +488.6% -98.0% +1,270.5% -216.1%
EBITDA Growth +224.0% -99.5% +10,687.3% -216.4%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2025-11-13 Sachetta Eric 0.00 $0.00 $0
2022-07-21 Rampolla Javier F-InKind 3,935.00 $10.51 $41,357
2023-01-03 Martinez Magdalena 0.00 $0.00 $0
2023-12-19 Martinez Magdalena F-InKind 741.00 $2.66 $1,971
2026-02-24 Sachetta Eric P-Purchase 2,000.00 $3.81 $7,620
2026-01-05 Biscotti Larry Joseph 0.00 $0.00 $0
2025-12-12 Sardano Michael A-Award 40,000.00 $0.00 $0
2025-11-18 Sardano Michael 0.00 $0.00 $0
2025-11-21 Sachetta Eric P-Purchase 7,000.00 $3.93 $27,510
2025-11-13 Sachetta Eric P-Purchase 2,500.00 $4.50 $11,250
2025-11-10 Sachetta Eric 0.00 $0.00 $0
2025-11-10 Sachetta Eric 0.00 $0.00 $0
2025-11-18 Sardano Joseph C P-Purchase 25,000.00 $4.03 $100,750
2025-11-18 Sardano Michael P-Purchase 1,000.00 $3.80 $3,800
2025-11-11 Sardano Michael P-Purchase 234.00 $4.34 $1,016
2025-11-11 Sardano Michael P-Purchase 766.00 $4.27 $3,271
2025-11-11 Sardano Michael P-Purchase 234.00 $4.24 $992
2025-11-11 Sardano Michael P-Purchase 766.00 $4.27 $3,271
2025-11-11 Sardano Michael P-Purchase 1,000.00 $4.26 $4,260
2025-08-13 Sardano Michael P-Purchase 1,000.00 $3.37 $3,370
Community AI Feedback
Sign in to Contribute
No community reviews yet for SRTS. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27